Literature DB >> 28661690

Hydrophobically Modified Polymer/α-Cyclodextrin Thermoresponsive Hydrogels for Use in Ocular Drug Delivery.

Daisuke Iohara1, Masanori Okubo1, Makoto Anraku1, Shunji Uramatsu2, Toshio Shimamoto2, Kaneto Uekama1, Fumitoshi Hirayama1.   

Abstract

We report herein on the preparation of thermoresponsive hydrogels by taking advantage of the interaction of cyclodextrins (CDs) and a hydrophobically modified polymer. A hydrophobically modified hydroxypropyl methylcellulose (HM-HPMC) gel formed thermoresponsive hydrogels when small amounts of α-CD were added to the solution. The HM-HPMC/α-CD showed reversible sol-gel transition in the physiological temperature range that was completely opposite to the temperature dependency shown by the original HM-HPMC. The thermoresponsive gelation was attributed to the temperature dependency of the interaction between α-CD and the hydrophobic moiety of HM-HPMC. The potency of the HM-HPMC/α-CD sol-gel transition system in ophthalmic formulation was tested on the eyes of a rabbit. The use of HM-HPMC/α-CD significantly improved the ocular absorption of a drug, diclofenac sodium, by virtue of the rapid formation of a gel on the ocular surface. That is, the HM-HPMC/α-CD was in a low viscous sol state at room temperature, which made administration easy, but it rapidly formed a viscous hydrogel on the ocular surface at physiological temperature. The thermoresponsive hydrogel based on the hydrophobically modified polymer and CD promises to have widespread applications in drug delivery.

Entities:  

Keywords:  cyclodextrins; hydrophobically modified polymer; ocular drug delivery; sol−gel transition; thermoresponsive hydrogel

Mesh:

Substances:

Year:  2017        PMID: 28661690     DOI: 10.1021/acs.molpharmaceut.7b00291

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Mildly Cross-Linked Dendrimer Hydrogel Prepared via Aza-Michael Addition Reaction for Topical Brimonidine Delivery.

Authors:  Juan Wang; Geoffrey S Williamson; Michael G Lancina Iii; Hu Yang
Journal:  J Biomed Nanotechnol       Date:  2017-12       Impact factor: 4.099

Review 2.  Combining Cellulose and Cyclodextrins: Fascinating Designs for Materials and Pharmaceutics.

Authors:  Tânia F Cova; Dina Murtinho; Alberto A C C Pais; Artur J M Valente
Journal:  Front Chem       Date:  2018-07-05       Impact factor: 5.221

3.  In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.

Authors:  Nushrat Yasmin; Yoichi Ishitsuka; Madoka Fukaura; Yusei Yamada; Shuichi Nakahara; Akira Ishii; Yuki Kondo; Toru Takeo; Naomi Nakagata; Keiichi Motoyama; Taishi Higashi; Yasuyo Okada; Junichi Nishikawa; Atsushi Ichikawa; Daisuke Iohara; Fumitoshi Hirayama; Katsumi Higaki; Kousaku Ohno; Muneaki Matsuo; Tetsumi Irie
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

Review 4.  Research progress of in-situ gelling ophthalmic drug delivery system.

Authors:  Yumei Wu; Yuanyuan Liu; Xinyue Li; Dereje Kebebe; Bing Zhang; Jing Ren; Jun Lu; Jiawei Li; Shouying Du; Zhidong Liu
Journal:  Asian J Pharm Sci       Date:  2018-05-24       Impact factor: 6.598

5.  Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.

Authors:  Soohyun Kim; Jennifer J Kang-Mieler; Wenqiang Liu; Zhe Wang; Glenn Yiu; Leandro B C Teixeira; William F Mieler; Sara M Thomasy
Journal:  Transl Vis Sci Technol       Date:  2020-02-27       Impact factor: 3.283

6.  Supramolecular Compartmentalized Hydrogels via Polydopamine Particle-Stabilized Water-in-Water Emulsions.

Authors:  Jianrui Zhang; Baris Kumru; Bernhard V K J Schmidt
Journal:  Langmuir       Date:  2019-08-15       Impact factor: 3.882

Review 7.  α-Cyclodextrin-Based Polypseudorotaxane Hydrogels.

Authors:  Adrian Domiński; Tomasz Konieczny; Piotr Kurcok
Journal:  Materials (Basel)       Date:  2019-12-28       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.